Title : The era of artificial intelligence (AI) and its use in regenerative medicine
Abstract:
The rapid evolution of artificial intelligence (AI) is reshaping the landscape of biomedical research and opening new possibilities in the field of regenerative medicine. Regenerative medicine aims to restore, replace, or regenerate damaged tissues and organs through the combined use of stem cells, biomaterials, tissue engineering, gene-based approaches, and advanced therapeutic strategies. However, the complexity of biological systems and the vast amount of multidimensional data generated by modern technologies present significant challenges that traditional analytical approaches cannot fully address. AI offers powerful computational solutions capable of transforming these challenges into opportunities for innovation.
Machine learning and deep learning algorithms are increasingly being integrated into regenerative medicine to analyse complex biological datasets, including genomic, transcriptomic, proteomic, imaging, and clinical information. These technologies enable the identification of critical molecular pathways, prediction of cell behaviour, optimization of stem cell differentiation protocols, and discovery of novel therapeutic targets. AI-assisted platforms are also accelerating the development of biomaterials and tissue-engineered constructs by predicting material properties, cellular responses, and optimal conditions for tissue regeneration.
One of the most promising applications of AI in regenerative medicine is the advancement of personalized therapies. By integrating patient-specific biological data with predictive computational models, AI has the potential to support the design of individualized regenerative treatments with improved efficacy and safety. Additionally, AI-powered imaging and monitoring systems provide accurate assessment of tissue development, organoid maturation, and therapeutic outcomes, thereby improving both research efficiency and clinical translation.
Despite its transformative potential, several challenges remain before AI can be fully integrated into regenerative medicine practice. These include the need for high-quality and standardized datasets, improved transparency and interpretability of AI models, ethical considerations, regulatory frameworks, and effective collaboration between clinicians, biologists, engineers, and data scientists. Overcoming these barriers will be essential to ensure the responsible and successful implementation of AI-driven regenerative technologies.
This presentation will highlight the current and emerging applications of artificial intelligence in regenerative medicine, focusing on its role in accelerating discovery, enhancing precision, and enabling next-generation therapeutic approaches. The convergence of AI and regenerative medicine represents a new era of biomedical innovation, with the potential to revolutionize tissue repair, disease modelling, and personalized healthcare.
